SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-027190
Filing Date
2021-11-04
Accepted
2021-11-04 07:19:13
Documents
68
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1357547
2 ex31-1.htm EX-31.1 14593
3 ex31-2.htm EX-31.2 9077
4 ex32-1.htm EX-32.1 6571
5 ex32-2.htm EX-32.2 6718
  Complete submission text file 0001493152-21-027190.txt   5322067

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prvb-20210930.xsd EX-101.SCH 39533
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prvb-20210930_cal.xml EX-101.CAL 51052
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prvb-20210930_def.xml EX-101.DEF 128715
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prvb-20210930_lab.xml EX-101.LAB 325426
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prvb-20210930_pre.xml EX-101.PRE 246476
11 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 741900
Mailing Address 55 BROAD STREET, 2ND FLOOR RED BANK NJ 07701
Business Address 55 BROAD STREET, 2ND FLOOR RED BANK NJ 07701 908-428-9136
Provention Bio, Inc. (Filer) CIK: 0001695357 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38552 | Film No.: 211377991
SIC: 2834 Pharmaceutical Preparations